| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 2.65e-05 | 10 | 123 | 3 | GO:0031698 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway | 5.45e-06 | 113 | 124 | 7 | GO:2001237 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PDE4D DAB2 HIP1R NDRG2 KIF20B RYR3 NEDD4 TG FAT1 SYNJ1 AIFM1 OSBPL3 PRKAR2A STH DOCK6 RAB29 MTMR9 | 5.10e-05 | 934 | 127 | 17 | GO:0048471 |
| GeneOntologyCellularComponent | centrosome | CCDC14 PDE4D USP9X CEP290 CHD4 BCL2L1 LCK KMT2E FIGN KIF20B AKAP9 PRKAR2A AJUBA PCM1 | 2.48e-04 | 770 | 127 | 14 | GO:0005813 |
| MousePheno | abnormal brain size | ANKFY1 TCF20 CASP9 ARID1A CSMD3 KIF20B TG AIFM1 RNF10 ARHGEF2 ADIPOR2 PCM1 | 1.62e-05 | 375 | 101 | 12 | MP:0000771 |
| Domain | BAF250/Osa | 4.44e-05 | 2 | 125 | 2 | IPR021906 | |
| Domain | BAF250_C | 4.44e-05 | 2 | 125 | 2 | IPR033388 | |
| Domain | BAF250_C | 4.44e-05 | 2 | 125 | 2 | PF12031 | |
| Domain | DHR-1_domain | 4.64e-05 | 11 | 125 | 3 | IPR027007 | |
| Domain | DHR_2 | 4.64e-05 | 11 | 125 | 3 | PS51651 | |
| Domain | DHR_1 | 4.64e-05 | 11 | 125 | 3 | PS51650 | |
| Domain | DHR-2 | 4.64e-05 | 11 | 125 | 3 | PF06920 | |
| Domain | DOCK | 4.64e-05 | 11 | 125 | 3 | IPR026791 | |
| Domain | DOCK_C | 4.64e-05 | 11 | 125 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 4.64e-05 | 11 | 125 | 3 | PF14429 | |
| Domain | DHR-2 | 4.64e-05 | 11 | 125 | 3 | IPR027357 | |
| Domain | LAM_G_DOMAIN | 1.18e-04 | 38 | 125 | 4 | PS50025 | |
| Domain | Fib_alpha | 1.33e-04 | 3 | 125 | 2 | SM01212 | |
| Domain | Fib_alpha | 1.33e-04 | 3 | 125 | 2 | PF08702 | |
| Domain | Fibrinogen_a/b/g_coil_dom | 1.33e-04 | 3 | 125 | 2 | IPR012290 | |
| Domain | Laminin_G_2 | 1.45e-04 | 40 | 125 | 4 | PF02210 | |
| Domain | LamG | 2.11e-04 | 44 | 125 | 4 | SM00282 | |
| Domain | Fibrinogen_CS | 2.62e-04 | 19 | 125 | 3 | IPR020837 | |
| Domain | - | 4.44e-04 | 95 | 125 | 5 | 2.60.120.200 | |
| Domain | Fibrinogen_a/b/g_C_2 | 5.34e-04 | 24 | 125 | 3 | IPR014715 | |
| Domain | - | 5.34e-04 | 24 | 125 | 3 | 4.10.530.10 | |
| Domain | ASX_HYDROXYL | 5.62e-04 | 100 | 125 | 5 | PS00010 | |
| Domain | Laminin_G | 6.14e-04 | 58 | 125 | 4 | IPR001791 | |
| Domain | DUF3398 | 6.55e-04 | 6 | 125 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 6.55e-04 | 6 | 125 | 2 | IPR021816 | |
| Domain | TNFR | 6.80e-04 | 26 | 125 | 3 | SM00208 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.32e-04 | 106 | 125 | 5 | IPR000152 | |
| Domain | Fibrinogen_C | 7.61e-04 | 27 | 125 | 3 | PF00147 | |
| Domain | Cadherin_CS | 8.31e-04 | 109 | 125 | 5 | IPR020894 | |
| Domain | FBG | 9.42e-04 | 29 | 125 | 3 | SM00186 | |
| Domain | CADHERIN_1 | 9.77e-04 | 113 | 125 | 5 | PS00232 | |
| Domain | Cadherin | 9.77e-04 | 113 | 125 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.02e-03 | 114 | 125 | 5 | PS50268 | |
| Domain | - | 1.02e-03 | 114 | 125 | 5 | 2.60.40.60 | |
| Domain | - | 1.04e-03 | 30 | 125 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.04e-03 | 30 | 125 | 3 | IPR014716 | |
| Domain | CA | 1.06e-03 | 115 | 125 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.10e-03 | 116 | 125 | 5 | IPR015919 | |
| Domain | Cadherin | 1.19e-03 | 118 | 125 | 5 | IPR002126 | |
| Domain | FIBRINOGEN_C_1 | 1.26e-03 | 32 | 125 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.26e-03 | 32 | 125 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.26e-03 | 32 | 125 | 3 | PS51406 | |
| Domain | EGF_CA | 1.38e-03 | 122 | 125 | 5 | SM00179 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 1.38e-03 | 33 | 125 | 3 | IPR001368 | |
| Domain | EGF-like_Ca-bd_dom | 1.48e-03 | 124 | 125 | 5 | IPR001881 | |
| Domain | DUF1220 | 1.55e-03 | 9 | 125 | 2 | SM01148 | |
| Domain | EGF_1 | 1.66e-03 | 255 | 125 | 7 | PS00022 | |
| Domain | EGF-like_CS | 1.89e-03 | 261 | 125 | 7 | IPR013032 | |
| Domain | IPPc | 1.93e-03 | 10 | 125 | 2 | IPR000300 | |
| Domain | IPPc | 1.93e-03 | 10 | 125 | 2 | SM00128 | |
| Domain | EGF_2 | 2.06e-03 | 265 | 125 | 7 | PS01186 | |
| Domain | DUF1220 | 2.35e-03 | 11 | 125 | 2 | PF06758 | |
| Domain | NBPF_dom | 2.35e-03 | 11 | 125 | 2 | IPR010630 | |
| Domain | NBPF | 2.35e-03 | 11 | 125 | 2 | PS51316 | |
| Domain | EGF_CA | 2.66e-03 | 86 | 125 | 4 | PF07645 | |
| Domain | TTL | 3.30e-03 | 13 | 125 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 3.30e-03 | 13 | 125 | 2 | IPR004344 | |
| Domain | TTL | 3.30e-03 | 13 | 125 | 2 | PF03133 | |
| Domain | ConA-like_dom | 3.58e-03 | 219 | 125 | 6 | IPR013320 | |
| Domain | EGF_Ca-bd_CS | 4.10e-03 | 97 | 125 | 4 | IPR018097 | |
| Domain | CUB | 4.31e-03 | 49 | 125 | 3 | PF00431 | |
| Domain | - | 4.41e-03 | 15 | 125 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 4.41e-03 | 15 | 125 | 2 | SM00501 | |
| Domain | ARID_dom | 4.41e-03 | 15 | 125 | 2 | IPR001606 | |
| Domain | ARID | 4.41e-03 | 15 | 125 | 2 | PS51011 | |
| Domain | ARID | 4.41e-03 | 15 | 125 | 2 | PF01388 | |
| Domain | EGF_CA | 4.41e-03 | 99 | 125 | 4 | PS01187 | |
| Domain | CUB | 4.56e-03 | 50 | 125 | 3 | SM00042 | |
| Domain | EGF_3 | 5.04e-03 | 235 | 125 | 6 | PS50026 | |
| Domain | - | 5.09e-03 | 52 | 125 | 3 | 2.60.120.290 | |
| Domain | Sushi | 5.09e-03 | 52 | 125 | 3 | PF00084 | |
| Domain | CUB | 5.37e-03 | 53 | 125 | 3 | PS01180 | |
| Domain | CCP | 5.66e-03 | 54 | 125 | 3 | SM00032 | |
| Domain | SUSHI | 6.27e-03 | 56 | 125 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.58e-03 | 57 | 125 | 3 | IPR000436 | |
| Domain | CUB_dom | 6.58e-03 | 57 | 125 | 3 | IPR000859 | |
| Domain | EGF-like_dom | 6.64e-03 | 249 | 125 | 6 | IPR000742 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK4 ANKFY1 DOCK11 USP9X NCF1 ARHGEF18 LCK FAM13A NISCH KCTD3 ARHGEF2 DOCK6 | 3.47e-05 | 450 | 92 | 12 | M27078 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK4 ANKFY1 DOCK11 USP9X NCF1 ARHGEF18 LCK FAM13A NISCH ARHGEF2 DOCK6 | 1.31e-04 | 439 | 92 | 11 | MM15595 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.45e-04 | 175 | 92 | 7 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.98e-04 | 184 | 92 | 7 | M41809 | |
| Pathway | REACTOME_IRAK4_DEFICIENCY_TLR2_4 | 2.04e-04 | 18 | 92 | 3 | M27464 | |
| Pubmed | ANKFY1 TCF20 DOCK11 USP9X KIF21A ARHGEF18 CHD4 NEDD4 SART1 AKAP9 CELSR2 SYNJ1 OSBPL3 NISCH PRKAR2A ARHGEF2 PCM1 | 9.94e-08 | 963 | 128 | 17 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 TCF20 DOCK11 INPP5E LCK LYST NEDD4 AKAP9 FAM13A SYNJ1 OSBPL3 RNF10 USP54 ARHGEF2 DOCK6 PCM1 | 1.22e-07 | 861 | 128 | 16 | 36931259 |
| Pubmed | FLG PCDHGC5 KIF21A DDX42 SRP72 CAT CHD4 ARID1A LYST SART1 ZNF608 TNN MYH15 OTUD3 ZNF350 UQCRC2 ARHGEF2 FUBP3 CCDC158 FCMR | 3.31e-07 | 1442 | 128 | 20 | 35575683 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ANKFY1 MARS1 USP9X SRP72 CAT PFKL SART1 AARS2 AIFM1 FGA FGB UQCRC2 FUBP3 | 4.16e-07 | 607 | 128 | 13 | 39147351 |
| Pubmed | ATP5IF1 DOCK11 USP9X ARID1A ARID1B AKAP9 USP54 ARHGEF2 DOCK6 FUBP3 PCM1 | 8.65e-07 | 446 | 128 | 11 | 24255178 | |
| Pubmed | 9.66e-07 | 6 | 128 | 3 | 30584065 | ||
| Pubmed | ZSWIM8 SYNM USP9X KIF21A CEP290 CHD4 ARID1A BRWD3 RYR3 NEUROD2 SYNJ1 SCG2 NISCH RNF10 C1S ZNF350 USP54 PCM1 | 1.19e-06 | 1285 | 128 | 18 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TCF20 MARS1 USP9X CEP290 DDX42 CAT CHD4 PFKL SART1 RPAP1 AARS2 AIFM1 UQCRC2 ARHGEF2 FUBP3 PCM1 | 1.21e-06 | 1024 | 128 | 16 | 24711643 |
| Pubmed | 1.29e-06 | 147 | 128 | 7 | 16959763 | ||
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.69e-06 | 7 | 128 | 3 | 22510986 | |
| Pubmed | 1.69e-06 | 7 | 128 | 3 | 16059920 | ||
| Pubmed | CCDC14 DOCK4 FLG CEP290 KIF20B FAT1 AKAP9 AARS2 SYNJ1 OSBPL3 RNF10 FGB PRKAR2A | 1.70e-06 | 689 | 128 | 13 | 36543142 | |
| Pubmed | 2.36e-06 | 103 | 128 | 6 | 10574462 | ||
| Pubmed | Casein kinase 1δ functions at the centrosome and Golgi to promote ciliogenesis. | 2.69e-06 | 8 | 128 | 3 | 24648492 | |
| Pubmed | CCDC14 ZSWIM8 FAT4 ATP5IF1 DAB2 PFKL AIFM1 SCG2 USP54 AJUBA FUBP3 PDZD4 | 2.75e-06 | 608 | 128 | 12 | 16713569 | |
| Pubmed | 4.02e-06 | 9 | 128 | 3 | 23834954 | ||
| Pubmed | ZSWIM8 TCF20 USP9X DDX42 SRP72 CHD4 ARID1A LARP4 SART1 UQCRC2 FUBP3 PCM1 | 5.68e-06 | 653 | 128 | 12 | 22586326 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DOCK11 USP9X CHD4 ARID1A LARP4 ARID1B AIFM1 NISCH USP54 ARHGEF2 | 5.70e-06 | 440 | 128 | 10 | 34244565 |
| Pubmed | DOCK4 ATP5IF1 ANKFY1 DOCK11 DDX42 ARHGEF18 CAT FAM13A NISCH PRKAR2A ARHGEF2 AJUBA DOCK6 FUBP3 | 7.57e-06 | 916 | 128 | 14 | 32203420 | |
| Pubmed | Vti1b promotes TRPV1 sensitization during inflammatory pain. | 7.93e-06 | 127 | 128 | 6 | 30335684 | |
| Pubmed | CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity. | 1.05e-05 | 12 | 128 | 3 | 27140400 | |
| Pubmed | 1.05e-05 | 12 | 128 | 3 | 21502359 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG TCEAL7 TCF20 ZC3H8 DDX42 SRP72 CHD4 ARID1A PCED1B SART1 ARID1B KCTD3 UQCRC2 ARHGEF2 DOCK6 | 1.12e-05 | 1082 | 128 | 15 | 38697112 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.15e-05 | 477 | 128 | 10 | 31300519 | |
| Pubmed | Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese. | 1.34e-05 | 2 | 128 | 2 | 11546832 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17414213 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11801602 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27164460 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 6165239 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 10960682 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 1.34e-05 | 2 | 128 | 2 | 37611161 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 32791957 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25555432 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 1.34e-05 | 2 | 128 | 2 | 28967863 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27231021 | ||
| Pubmed | Fibrinogen polymorphisms are not associated with the risk of myocardial infarction. | 1.34e-05 | 2 | 128 | 2 | 11054085 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30838756 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22484628 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34386776 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23238100 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23202128 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 33890484 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11833854 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 1.34e-05 | 2 | 128 | 2 | 24562383 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 16086292 | ||
| Pubmed | Identification of a novel mutation in congenital afibrinogenemia in Iranian patients. | 1.34e-05 | 2 | 128 | 2 | 33901106 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22552295 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19143925 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24367264 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 1.34e-05 | 2 | 128 | 2 | 29890703 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20533267 | ||
| Pubmed | A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. | 1.34e-05 | 2 | 128 | 2 | 9182580 | |
| Pubmed | The endocytic adaptor protein Disabled-2 is required for cellular uptake of fibrinogen. | 1.34e-05 | 2 | 128 | 2 | 22705885 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 24788099 | ||
| Pubmed | Fibrinogen genes modify the fibrinogen response to ambient particulate matter. | 1.34e-05 | 2 | 128 | 2 | 19136375 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 33052929 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 11460506 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34061326 | ||
| Pubmed | Interaction Between Platelet and Fibrinogen on Clot Strength in Healthy Patients. | 1.34e-05 | 2 | 128 | 2 | 36933991 | |
| Pubmed | Nucleotide sequences of the three genes coding for human fibrinogen. | 1.34e-05 | 2 | 128 | 2 | 2102623 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 6575700 | ||
| Pubmed | Genetic associations between fibrinogen and cognitive performance in three Scottish cohorts. | 1.34e-05 | 2 | 128 | 2 | 21258858 | |
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 1.34e-05 | 2 | 128 | 2 | 27562491 | |
| Pubmed | MARS1 INPP5E KIF21A SRP72 CHD4 BCL2L1 PFKL ARID1A ISY1 SART1 AKAP9 RNF6 ZNF608 AIFM1 PRKAR2A ARHGEF2 | 1.46e-05 | 1247 | 128 | 16 | 27684187 | |
| Pubmed | 1.51e-05 | 390 | 128 | 9 | 17643375 | ||
| Pubmed | ZSWIM8 FAT3 CHD4 ARID1A BRWD3 ISY1 SART1 FAT1 ARID1B ZNF608 OSBPL3 FGB USP54 CSMD1 PCM1 | 1.61e-05 | 1116 | 128 | 15 | 31753913 | |
| Pubmed | 1.72e-05 | 14 | 128 | 3 | 21873192 | ||
| Pubmed | 1.72e-05 | 14 | 128 | 3 | 12432077 | ||
| Pubmed | 1.80e-05 | 399 | 128 | 9 | 37536630 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 DOCK11 KIF21A CEP290 PFKL CHRNB4 NEUROD2 RPAP1 AIFM1 FUBP3 ADIPOR2 MTMR9 | 1.87e-05 | 736 | 128 | 12 | 29676528 |
| Pubmed | 2.11e-05 | 407 | 128 | 9 | 12693553 | ||
| Pubmed | 2.60e-05 | 418 | 128 | 9 | 35338135 | ||
| Pubmed | MARS1 USP9X CEP290 DDX42 CAT CHD4 PFKL LARP4 ITGB7 LGALS8 OSBPL3 NISCH PRKAR2A FUBP3 PCM1 | 2.72e-05 | 1168 | 128 | 15 | 19946888 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ATP5IF1 SYNM SRP72 CAT LARP4 AKAP9 RPAP1 AARS2 AIFM1 OSBPL3 NISCH FGA PRKAR2A UQCRC2 ARHGEF2 RAB29 FUBP3 | 3.62e-05 | 1496 | 128 | 17 | 32877691 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ANKFY1 TCF20 MARS1 KIF21A HIP1R CAT CHD4 PFKL ARID1A LARP4 KIF20B SART1 AIFM1 UQCRC2 ARHGEF2 FUBP3 | 3.91e-05 | 1353 | 128 | 16 | 29467282 |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 32126779 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 15217804 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 12906867 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 16144795 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33558447 | ||
| Pubmed | A non-apoptotic role for caspase-9 in muscle differentiation. | 4.02e-05 | 3 | 128 | 2 | 18957517 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28223545 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 1680863 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 21647563 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25872771 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19190816 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 32877852 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 12750384 | ||
| Pubmed | Patched dependence receptor triggers apoptosis through ubiquitination of caspase-9. | 4.02e-05 | 3 | 128 | 2 | 22679284 | |
| Pubmed | The role of betagamma and alphagamma complexes in the assembly of human fibrinogen. | 4.02e-05 | 3 | 128 | 2 | 8910396 | |
| Pubmed | The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition. | 4.02e-05 | 3 | 128 | 2 | 23171055 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 4.02e-05 | 3 | 128 | 2 | 15744052 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 17849064 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 18331453 | ||
| Pubmed | Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. | 4.02e-05 | 3 | 128 | 2 | 22489912 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 6383194 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22642105 | ||
| Pubmed | PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome. | 4.02e-05 | 3 | 128 | 2 | 22908311 | |
| Pubmed | The X-linked deubiquitinase USP9X is an integral component of centrosome. | 4.02e-05 | 3 | 128 | 2 | 28620049 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 19750100 | ||
| Interaction | DCANP1 interactions | 5.42e-06 | 19 | 127 | 4 | int:DCANP1 | |
| Interaction | KIAA1328 interactions | 6.48e-06 | 42 | 127 | 5 | int:KIAA1328 | |
| Interaction | LOC254896 interactions | 7.30e-06 | 43 | 127 | 5 | int:LOC254896 | |
| Interaction | YWHAZ interactions | PDE4D DOCK11 INPP5E HIP1R ARHGEF18 CAT PFKL LCK ARID1A LYST NEDD4 CRACD AKAP9 FAM13A OSBPL3 NISCH PRKAR2A UQCRC2 USP54 ARHGEF2 AJUBA ADIPOR2 PCM1 | 7.56e-06 | 1319 | 127 | 23 | int:YWHAZ |
| Interaction | C2CD4B interactions | 8.19e-06 | 44 | 127 | 5 | int:C2CD4B | |
| Interaction | CEP135 interactions | CCDC14 ATP5IF1 SYNM CEP290 SRP72 KIF20B AKAP9 CARD9 USP54 PCM1 | 8.89e-06 | 272 | 127 | 10 | int:CEP135 |
| Interaction | FBXO10 interactions | 9.17e-06 | 45 | 127 | 5 | int:FBXO10 | |
| Interaction | CARD16 interactions | 2.00e-05 | 9 | 127 | 3 | int:CARD16 | |
| Interaction | SIRT6 interactions | FAT4 DOCK11 USP9X FAT3 CHD4 ARID1A LARP4 FAT1 ARID1B CELSR2 AIFM1 NISCH USP54 ARHGEF2 | 4.27e-05 | 628 | 127 | 14 | int:SIRT6 |
| Interaction | TIAM1 interactions | 4.76e-05 | 205 | 127 | 8 | int:TIAM1 | |
| Interaction | CCDC8 interactions | MARS1 USP9X CEP290 CAT CHD4 PFKL LCK SART1 RPAP1 AARS2 AIFM1 UQCRC2 ARHGEF2 PCM1 | 6.83e-05 | 656 | 127 | 14 | int:CCDC8 |
| Interaction | KRT19 interactions | 7.60e-05 | 282 | 127 | 9 | int:KRT19 | |
| GeneFamily | Cadherin related | 8.78e-05 | 17 | 94 | 3 | 24 | |
| GeneFamily | Fibrinogen C domain containing | 2.88e-04 | 25 | 94 | 3 | 554 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 5.81e-06 | 200 | 126 | 8 | M8088 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN | 2.39e-05 | 71 | 126 | 5 | M707 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | DOCK4 FAT4 PDE4D ZC3H8 FAT3 KIF21A STK32B CSMD3 ZNF25 AKAP9 SCG2 CSMD1 | 2.59e-05 | 584 | 126 | 12 | M39068 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 4.68e-05 | 196 | 126 | 7 | M9243 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BCELL_DN | 4.99e-05 | 198 | 126 | 7 | M5521 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 5.15e-05 | 199 | 126 | 7 | M7319 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | 5.15e-05 | 199 | 126 | 7 | M7651 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 5.32e-05 | 200 | 126 | 7 | M9484 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 5.32e-05 | 200 | 126 | 7 | M9136 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 7.90e-05 | 213 | 126 | 7 | M12176 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-09 | 184 | 128 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-09 | 184 | 128 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-09 | 184 | 128 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 9.13e-08 | 193 | 128 | 8 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-08 | 195 | 128 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 184 | 128 | 7 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 195 | 128 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 197 | 128 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-06 | 198 | 128 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.85e-06 | 200 | 128 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-06 | 200 | 128 | 7 | 68589705dbc84482b6c0a1a27dd552492c4e8c3d | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.12e-06 | 146 | 128 | 6 | bb7bf20245d93c8812920dd0debbf1ed00add378 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 171 | 128 | 6 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 172 | 128 | 6 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 176 | 128 | 6 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 176 | 128 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 176 | 128 | 6 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 176 | 128 | 6 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-05 | 176 | 128 | 6 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 176 | 128 | 6 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.28e-05 | 178 | 128 | 6 | dff7a59e53a7329212689ca234931ed4a1b67eee | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 180 | 128 | 6 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-05 | 181 | 128 | 6 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-05 | 184 | 128 | 6 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-05 | 184 | 128 | 6 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 187 | 128 | 6 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.75e-05 | 188 | 128 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.97e-05 | 192 | 128 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-05 | 193 | 128 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 195 | 128 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.21e-05 | 196 | 128 | 6 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 196 | 128 | 6 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.27e-05 | 197 | 128 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 198 | 128 | 6 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 128 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.47e-05 | 200 | 128 | 6 | 670ef1e68be0d2c6ea20ab4dea1d051a3cc89799 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 127 | 128 | 5 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-05 | 147 | 128 | 5 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-05 | 149 | 128 | 5 | 5a5e9660f7d9b527f50a92d94d4c0c8aedb82c0b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-05 | 149 | 128 | 5 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-05 | 150 | 128 | 5 | 1f83e3be3f94aefe991a3ccd292c2d11ddef858e | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-05 | 150 | 128 | 5 | cd666db614bc1b43d71e8eb7bf38cae4d580be80 | |
| ToppCell | facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.33e-05 | 150 | 128 | 5 | f6ed3e7b36014d1e429b255b0027d89865e1ac07 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 8.30e-05 | 154 | 128 | 5 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.30e-05 | 154 | 128 | 5 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.09e-05 | 157 | 128 | 5 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.09e-05 | 157 | 128 | 5 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.09e-05 | 157 | 128 | 5 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.37e-05 | 158 | 128 | 5 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.37e-05 | 158 | 128 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 160 | 128 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.94e-05 | 160 | 128 | 5 | e4516b093003275084fc327d1597394a436754eb | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.94e-05 | 160 | 128 | 5 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 160 | 128 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.94e-05 | 160 | 128 | 5 | 0a507e3d59d7f744d0201a531ea84fa97a68aedb | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 84 | 128 | 4 | 013cf97d08d0adb3697cf2a146ff5ca13c676f64 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 161 | 128 | 5 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 161 | 128 | 5 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 163 | 128 | 5 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 163 | 128 | 5 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 163 | 128 | 5 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 164 | 128 | 5 | cfe07a1ebed8aecb08d0476db71fe314998d54aa | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-plasmacytoid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 164 | 128 | 5 | 6d331e74efecb4733d87653f86cd67247be05025 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 1.12e-04 | 164 | 128 | 5 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | Mild-Lymphoid-NK-CD8_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.15e-04 | 165 | 128 | 5 | 9b0b037383e3e7cf7cfbc65b8d4c4721be3210f8 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 165 | 128 | 5 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 165 | 128 | 5 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 165 | 128 | 5 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.15e-04 | 165 | 128 | 5 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.18e-04 | 166 | 128 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 166 | 128 | 5 | 82fa07632f7e586698fbf37381715b40f9f6ae3a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 166 | 128 | 5 | 0d03926452414f232c77fd15d5f48d148f9fca3b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 167 | 128 | 5 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 167 | 128 | 5 | b742558ca92985db0a67c88f530bc375f3d3bb98 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 168 | 128 | 5 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 128 | 5 | 1254c66f0cd53ef3b913933c0b0648d091da07e9 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 128 | 5 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 169 | 128 | 5 | 630d921aa8fb5681d06a4e09b833855c374be484 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 169 | 128 | 5 | 468284d4a3a0557aed04eadb1aba2317babc6904 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 169 | 128 | 5 | 6f765e142d127545e622fe24b5287cd6e9706ccc | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 169 | 128 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 169 | 128 | 5 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-04 | 170 | 128 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.32e-04 | 170 | 128 | 5 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.32e-04 | 170 | 128 | 5 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 170 | 128 | 5 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.32e-04 | 170 | 128 | 5 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 1.39e-04 | 172 | 128 | 5 | c3822ff7329c3ac38c68c5c38cd67c390682e2a6 | |
| ToppCell | control-Myeloid-Mast_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.39e-04 | 172 | 128 | 5 | c1c99e6732234a6649a79610e99390db0c8f19b0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 173 | 128 | 5 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 173 | 128 | 5 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK_CD56bright|Int-URO / Disease, Lineage and Cell Type | 1.47e-04 | 174 | 128 | 5 | 93c7acd5941a5f235ec4c57461f78ee2871e7336 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 174 | 128 | 5 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | NS-control-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-04 | 174 | 128 | 5 | 2d1f5c17b1551f32f49618ec1bf68eafbfd02ace | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 175 | 128 | 5 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 175 | 128 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-04 | 176 | 128 | 5 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 176 | 128 | 5 | 5f8c1f917fba49f3b1c0d88b946eca242b668fde | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-04 | 176 | 128 | 5 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 177 | 128 | 5 | 7d73643beb007032e757f2611121c4f3027aecf5 | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.53e-06 | 195 | 127 | 9 | 5313_UP | |
| Drug | Amitrole | 4.05e-06 | 43 | 127 | 5 | ctd:D000640 | |
| Drug | 2-amino-4,5-diphenylthiazole | 5.84e-06 | 7 | 127 | 3 | CID000073222 | |
| Drug | 1-methyl-2-nitro-1-nitrosoguanidine | 7.79e-06 | 238 | 127 | 9 | CID000006261 | |
| Drug | Thymol | 1.25e-05 | 26 | 127 | 4 | ctd:D013943 | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; HL60; HG-U133A | 1.69e-05 | 200 | 127 | 8 | 1594_DN | |
| Drug | Zithromac | 1.96e-05 | 99 | 127 | 6 | CID000002269 | |
| Drug | tetraglyme | 1.98e-05 | 10 | 127 | 3 | CID000008925 | |
| Disease | Squamous cell carcinoma of esophagus | 3.59e-06 | 95 | 127 | 6 | C0279626 | |
| Disease | Hereditary factor I deficiency disease | 5.50e-05 | 3 | 127 | 2 | cv:C0019250 | |
| Disease | Familial dysfibrinogenemia | 5.50e-05 | 3 | 127 | 2 | cv:C0272350 | |
| Disease | Congenital afibrinogenemia | 5.50e-05 | 3 | 127 | 2 | cv:C2584774 | |
| Disease | AFIBRINOGENEMIA, CONGENITAL | 5.50e-05 | 3 | 127 | 2 | 202400 | |
| Disease | congenital afibrinogenemia (is_implicated_in) | 5.50e-05 | 3 | 127 | 2 | DOID:2236 (is_implicated_in) | |
| Disease | Hashimoto Disease | 5.50e-05 | 3 | 127 | 2 | C0677607 | |
| Disease | DYSFIBRINOGENEMIA, CONGENITAL | 5.50e-05 | 3 | 127 | 2 | 616004 | |
| Disease | keratoconjunctivitis (is_marker_for) | 5.50e-05 | 3 | 127 | 2 | DOID:9368 (is_marker_for) | |
| Disease | Dysfibrinogenemia, Congenital | 5.50e-05 | 3 | 127 | 2 | C0272350 | |
| Disease | sunburn | 6.10e-05 | 96 | 127 | 5 | EFO_0003958 | |
| Disease | bacterial pneumonia (implicated_via_orthology) | 1.10e-04 | 4 | 127 | 2 | DOID:874 (implicated_via_orthology) | |
| Disease | acne (is_marker_for) | 1.10e-04 | 4 | 127 | 2 | DOID:6543 (is_marker_for) | |
| Disease | Afibrinogenemia | 1.10e-04 | 4 | 127 | 2 | C0001733 | |
| Disease | Congenital hypofibrinogenemia | 1.10e-04 | 4 | 127 | 2 | C2584774 | |
| Disease | Fibrinogen Deficiency | 1.82e-04 | 5 | 127 | 2 | C4316812 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.82e-04 | 5 | 127 | 2 | C3281201 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.46e-04 | 139 | 127 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | catalase measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0008071 | |
| Disease | stomach cancer (is_marker_for) | 3.82e-04 | 142 | 127 | 5 | DOID:10534 (is_marker_for) | |
| Disease | response to radiation | 5.77e-04 | 88 | 127 | 4 | GO_0009314 | |
| Disease | pancreatitis (biomarker_via_orthology) | 6.35e-04 | 39 | 127 | 3 | DOID:4989 (biomarker_via_orthology) | |
| Disease | Retinal Pigment Epithelial Detachment | 6.49e-04 | 9 | 127 | 2 | C0339546 | |
| Disease | post-operative sensory disturbance | 6.49e-04 | 9 | 127 | 2 | EFO_0005324 | |
| Disease | cutaneous leishmaniasis (is_marker_for) | 8.09e-04 | 10 | 127 | 2 | DOID:9111 (is_marker_for) | |
| Disease | Carotid Circulation Transient Ischemic Attack | 8.09e-04 | 10 | 127 | 2 | C0751019 | |
| Disease | Transient Ischemic Attack | 8.09e-04 | 10 | 127 | 2 | C0007787 | |
| Disease | neuroblastoma (is_implicated_in) | 8.09e-04 | 10 | 127 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Crescendo Transient Ischemic Attacks | 8.09e-04 | 10 | 127 | 2 | C0751021 | |
| Disease | Transient Ischemic Attack, Vertebrobasilar Circulation | 8.09e-04 | 10 | 127 | 2 | C0751020 | |
| Disease | Brain Stem Ischemia, Transient | 8.09e-04 | 10 | 127 | 2 | C0751022 | |
| Disease | vitamin B6 measurement | 8.09e-04 | 10 | 127 | 2 | EFO_0004621 | |
| Disease | Posterior Circulation Transient Ischemic Attack | 8.09e-04 | 10 | 127 | 2 | C0472381 | |
| Disease | Transient Ischemic Attack, Anterior Circulation | 8.09e-04 | 10 | 127 | 2 | C1527335 | |
| Disease | Transient Cerebral Ischemia | 8.09e-04 | 10 | 127 | 2 | C0917805 | |
| Disease | dry eye syndrome (is_marker_for) | 8.09e-04 | 10 | 127 | 2 | DOID:10140 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease, chronic bronchitis | 8.09e-04 | 10 | 127 | 2 | EFO_0000341, EFO_0006505 | |
| Disease | Malignant Head and Neck Neoplasm | 9.06e-04 | 44 | 127 | 3 | C0278996 | |
| Disease | Colorectal Carcinoma | ABCB6 ARID1A CSMD3 FANCG FAT1 AKAP9 RPAP1 TLR2 UQCRC2 ST8SIA4 | 9.40e-04 | 702 | 127 | 10 | C0009402 |
| Disease | Autistic Disorder | 9.58e-04 | 261 | 127 | 6 | C0004352 | |
| Disease | Retinal Detachment | 9.86e-04 | 11 | 127 | 2 | C0035305 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.14e-03 | 181 | 127 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Pulmonary Thromboembolisms | 1.18e-03 | 12 | 127 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 1.18e-03 | 12 | 127 | 2 | C0034065 | |
| Disease | pulmonary embolism (biomarker_via_orthology) | 1.18e-03 | 12 | 127 | 2 | DOID:9477 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.24e-03 | 49 | 127 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Streptozotocin Diabetes | 1.24e-03 | 108 | 127 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.24e-03 | 108 | 127 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 1.24e-03 | 108 | 127 | 4 | C0002152 | |
| Disease | cognitive function measurement | ANKFY1 PDE4D TCF20 STK32B KMT2E FIGN CSMD3 RYR3 ARID1B ZNF608 TTLL2 RNF10 MYH15 CLNK AJUBA | 1.31e-03 | 1434 | 127 | 15 | EFO_0008354 |
| Disease | Cholestasis | 1.33e-03 | 110 | 127 | 4 | C0008370 | |
| Disease | lung disease (implicated_via_orthology) | 1.39e-03 | 13 | 127 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | cataract (biomarker_via_orthology) | 1.39e-03 | 13 | 127 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.39e-03 | 13 | 127 | 2 | C0265338 | |
| Disease | gastric ulcer (implicated_via_orthology) | 1.62e-03 | 14 | 127 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Alzheimer disease, visuospatial impairment | 1.62e-03 | 14 | 127 | 2 | EFO_0009752, MONDO_0004975 | |
| Disease | peripheral arterial disease | 1.65e-03 | 54 | 127 | 3 | EFO_0004265 | |
| Disease | Polydactyly | 1.67e-03 | 117 | 127 | 4 | C0152427 | |
| Disease | triacylglycerol 52:2 measurement | 1.73e-03 | 55 | 127 | 3 | EFO_0010414 | |
| Disease | phospholipids in medium HDL measurement | 1.73e-03 | 55 | 127 | 3 | EFO_0022295 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.86e-03 | 15 | 127 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Graves' disease (is_marker_for) | 1.86e-03 | 15 | 127 | 2 | DOID:12361 (is_marker_for) | |
| Disease | colorectal cancer (is_implicated_in) | 1.89e-03 | 121 | 127 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | total lipids in medium HDL measurement | 2.02e-03 | 58 | 127 | 3 | EFO_0022310 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 2.12e-03 | 16 | 127 | 2 | EFO_0004792, HP_0002140 | |
| Disease | angina pectoris | 2.12e-03 | 125 | 127 | 4 | EFO_0003913 | |
| Disease | cholesterol in medium HDL measurement | 2.12e-03 | 59 | 127 | 3 | EFO_0021903 | |
| Disease | phospholipids in HDL measurement | 2.34e-03 | 61 | 127 | 3 | EFO_0022293 | |
| Disease | otitis media (biomarker_via_orthology) | 2.40e-03 | 17 | 127 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | factor XI measurement, Ischemic stroke | 2.40e-03 | 17 | 127 | 2 | EFO_0004694, HP_0002140 | |
| Disease | tuberculosis | 2.48e-03 | 216 | 127 | 5 | MONDO_0018076 | |
| Disease | carcinoma (implicated_via_orthology) | 2.68e-03 | 64 | 127 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | interstitial lung disease | 3.05e-03 | 67 | 127 | 3 | EFO_0004244 | |
| Disease | joint damage measurement | 3.18e-03 | 68 | 127 | 3 | EFO_0005413 | |
| Disease | Familial aplasia of the vermis | 3.32e-03 | 20 | 127 | 2 | cv:C0431399 | |
| Disease | Lupus Erythematosus, Systemic | 3.60e-03 | 71 | 127 | 3 | C0024141 | |
| Disease | vitiligo (is_implicated_in) | 3.66e-03 | 21 | 127 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 3.66e-03 | 21 | 127 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 4.01e-03 | 22 | 127 | 2 | DOID:12930 (biomarker_via_orthology) | |
| Disease | lymphocyte count, response to vaccine | 4.01e-03 | 22 | 127 | 2 | EFO_0004587, EFO_0004645 | |
| Disease | otitis media (implicated_via_orthology) | 4.01e-03 | 22 | 127 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | lung disease (is_implicated_in) | 4.01e-03 | 22 | 127 | 2 | DOID:850 (is_implicated_in) | |
| Disease | respiratory symptom measurement, COVID-19 | 4.04e-03 | 74 | 127 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | neuritic plaque measurement | 4.09e-03 | 349 | 127 | 6 | EFO_0006798 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSGRFRQDVQEALEG | 416 | P30926 | |
| DNSSRFSLNGGANIE | 3631 | Q99996 | |
| GDLLVQQFSGENGER | 531 | Q6ZSZ5 | |
| ENGRRAGSDFRVGAN | 356 | Q96PZ7 | |
| INARRFGDNFQLGSS | 841 | Q7Z407 | |
| SGEVRRFNTANDDNV | 426 | P04040 | |
| SDFGGFRVNAELQAR | 416 | O95831 | |
| EQGSLDAERNQRGSF | 66 | Q96IF1 | |
| RADSDSSQRDRNGNQ | 716 | Q92974 | |
| RHNEGDDQQGSRYSV | 261 | Q9UKT5 | |
| GNTNQEFRIDSVTGA | 2196 | Q6V0I7 | |
| ADNIRYGRVTAGNDE | 681 | Q9NP58 | |
| GNNAAAESRKGQERF | 196 | Q07817 | |
| NQGRRTVLYNDDSDN | 1751 | Q6RI45 | |
| DRSDKLGRVQEFNSG | 1871 | Q8NFD5 | |
| FAERLQRNESGLDSG | 2036 | Q9HCU4 | |
| QRNESGLDSGRSQQL | 2041 | Q9HCU4 | |
| SASRQTRNEEQSGDG | 566 | P20930 | |
| SRQTRNEEQSGDGSR | 1541 | P20930 | |
| SRQTRNDEQSGDGSR | 3486 | P20930 | |
| RQGEEDRENTTGSDN | 516 | Q9H257 | |
| TSRDEQDFRNGLAAL | 921 | Q49A88 | |
| FSRTEQLADGQAGRG | 1456 | O60312 | |
| DDALEGSASNTQGRQ | 571 | Q96M43 | |
| QLDGTRRGDNDSHQG | 26 | Q86V24 | |
| ANYRGGEIREQNGDS | 251 | P22695 | |
| RDQIDRFSKENGFTG | 136 | O14966 | |
| RSNSVGIQDAFNDGS | 1181 | O14497 | |
| EFGANVNAQDAEGRT | 791 | Q9P2R3 | |
| RTQNGVSEREQNGFS | 376 | P98082 | |
| PSDSRNNLDRNSFEG | 4261 | Q14517 | |
| ISNTNRGNGFDRSAE | 356 | Q5HY92 | |
| VFNAGSDERANSRDE | 6 | Q9BZ81 | |
| GNEGKVDNLSRDSNR | 491 | P46934 | |
| FRGSQEDLEARNGTS | 96 | Q9NRR6 | |
| SDADRFQVDLQNGSS | 41 | O00214 | |
| ASQFGTFLGNNESER | 431 | Q96QG7 | |
| QNAGLGEFRIRDLND | 61 | Q9ULR0 | |
| FNQRGTRLASSGDDL | 236 | P0C7V8 | |
| GANDGRNGESRKEAF | 876 | Q86XP3 | |
| QGVNDNEEGFFSARG | 31 | P02675 | |
| DLDQRSIGSDSQGRA | 111 | Q15154 | |
| LFNVRDRDSGRNGEV | 371 | Q9Y5F6 | |
| SGGNSALDVNRNESL | 381 | Q76G19 | |
| RFDEATQLRGGSFEN | 366 | P17858 | |
| SFQGLRRFDVDNGTS | 146 | Q08499 | |
| GQLRARGELNFEQDE | 46 | Q96HM7 | |
| FDGQRAAENRQGTLT | 81 | P14598 | |
| RNKFGQLGLNDENDR | 216 | Q5GLZ8 | |
| DQADFRGVRGDFNSR | 236 | Q96I24 | |
| QNEGERLRETGNINT | 391 | Q96Q89 | |
| SGFGRTVNDNLIDGN | 1131 | Q8IZD2 | |
| GSFSLSVRDFDQNQG | 161 | P06239 | |
| GINGGDFDTFQNLRD | 1596 | P98088 | |
| RASLAQGFTEDQAQD | 81 | O15287 | |
| FQDGRNDVQESSLRD | 141 | O94988 | |
| TGDAQAFEREVGRQS | 236 | P26010 | |
| AFEREVGRQSVSGNL | 241 | P26010 | |
| RIFGNQGLNEGRTEN | 306 | Q5T2D3 | |
| SSQEQGELQGRLAER | 591 | O75146 | |
| GDGRQNLFSFDSEVQ | 331 | Q5JSL3 | |
| RRLFSLATGGQNEEE | 716 | Q8N1I0 | |
| RQVFEQDASGDERSG | 151 | Q96HP0 | |
| ERRGFSEGGRQNFDV | 16 | Q8WVX3 | |
| AQQSAGGRDTRFLRN | 101 | O15078 | |
| EDIQRAGSGSRRDQA | 41 | P55211 | |
| RREQQGRSGDFQGAD | 461 | Q6ZU35 | |
| NGNFALRITATDGEN | 646 | Q8TDW7 | |
| NLRGSGDGRNVYQEV | 4211 | Q8TDW7 | |
| DTEEGRLCGQRSSNN | 76 | P09871 | |
| QLGEQRSEQQDSGRE | 131 | A1A5D9 | |
| AQGDQGLERRIDQAF | 371 | Q9Y600 | |
| LNDRNEFSGDSSEQR | 171 | O94769 | |
| NREGFDFGVRQNGER | 3306 | Q99698 | |
| EILRGDFSSANNRDN | 111 | P02671 | |
| STLQVEQNGDYGRGR | 431 | Q71RC2 | |
| DNQTRSVGQYDNRGS | 191 | P13861 | |
| ARTERDQFSQESGNL | 361 | Q5M9N0 | |
| QARGFGSDQSENVDR | 21 | Q9UII2 | |
| TRNFEALNARGGGNQ | 991 | Q14839 | |
| TGREAVENVNFRSLG | 436 | Q92681 | |
| FNLQRQGSRENGSVE | 741 | Q9UJQ4 | |
| ADSRNGLNSTEGEAR | 146 | Q9Y597 | |
| AGRFRVENGSSDENA | 61 | Q5VVW2 | |
| SGDNLAEENSRDENR | 416 | Q9H4L5 | |
| NFGEVFSGRLRADNT | 571 | P07332 | |
| RTGQRAQENYEGSEE | 2531 | Q93008 | |
| RDADSRNDQAVGVSF | 1491 | O15061 | |
| RAGTRFNVRGTNDDG | 211 | O43426 | |
| SYNNRRDLNFERGGD | 236 | Q9UN36 | |
| DDALEGSASNTQGRQ | 571 | Q5VWK0 | |
| NRENQSILFTGESGA | 186 | Q9Y2K3 | |
| SGELEQRLSGEFSRQ | 616 | Q96NG3 | |
| LQNGQNGERATRLFE | 326 | P13521 | |
| QSGGSELRQREGQRF | 261 | Q9Y252 | |
| RDEGEFTCRAQNAQG | 321 | Q9NYZ4 | |
| QRAFGGFRNESDREK | 196 | Q92187 | |
| DTTQNLGERVNDIGF | 141 | Q9BXF9 | |
| SEVNRYGQNGDFTRA | 16 | O76094 | |
| TENGENFSVGERQLL | 1251 | Q96J65 | |
| RTNFYAEQGGQASDR | 561 | Q5JTZ9 | |
| QASDRGYLVRAGQED | 571 | Q5JTZ9 | |
| RNQQFALGTGLRGDE | 366 | Q7Z7G1 | |
| TFQDSAGARNNRDGN | 11 | Q2HXU8 | |
| GEFERQQTEGNFRQR | 26 | Q9BRU2 | |
| FQDETGKNRRQSGSF | 196 | Q9H4F1 | |
| LQGDNRSYSQEGSRE | 591 | A0A0J9YY54 | |
| REDQRFALQGLEQGA | 1021 | Q9UQP3 | |
| IQGDNLFSGSRDNGI | 1551 | Q7Z4S6 | |
| ADDQAFVFEGNRGQR | 1116 | Q15413 | |
| FNGGRRDEVAEAQRA | 111 | Q8N5U6 | |
| QRALDYGSQSGREGQ | 236 | O60667 | |
| SFADGQPAERRASND | 1026 | Q9Y2I1 | |
| YLNGLRNEGREASNA | 416 | Q9BWV7 | |
| EESSRNGAEQGRQLS | 81 | Q8IWL8 | |
| KLEERGANQDSRNGS | 226 | Q86TL2 | |
| QVISRAQAGEFGDRL | 416 | Q9BWH6 | |
| SSEDQGERVRQLSGQ | 526 | Q9UGU0 | |
| LGDQTQDGDFGSRLR | 426 | O43290 | |
| ASGDNRGFAQDRNLV | 496 | Q9GZX5 | |
| ANGFFEEIRQGNIER | 21 | O14668 | |
| LANGSADEFQRGDQL | 126 | A7E2V4 | |
| RYQESQAGNSRNGEL | 91 | P17030 | |
| SGDCRQQEFRDRSGN | 31 | Q9NS68 | |
| NEGLANGLSESQESR | 861 | Q9ULD9 | |
| RRQQGQGSQLLDTDS | 371 | Q9NY57 | |
| AGRNRTVEVFDLNAG | 676 | A2RRH5 | |
| GVGNFRASDNDRVID | 291 | O60603 | |
| QALQNSLGGEDSDAR | 2541 | P01266 | |
| ENDQIESLRQRFGGG | 806 | P56192 | |
| QEETLARRDSFAGNG | 571 | Q9Y6Q6 | |
| LDELQNQGRSDGFER | 781 | Q70EL1 | |
| NQGRSDGFERSLQEA | 786 | Q70EL1 | |
| ARDQNQGESAGEKSR | 536 | A6NNM8 | |
| SNALLRNSGSQEEDG | 156 | Q8N5P1 | |
| NSRNFLTEQGADGAG | 211 | Q15784 |